The STEAP4 target NQO1 mediates colon tumorigenesis
Authors:
Open Access
- 15 May 2025
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 138 (10)
Abstract
Colorectal cancer (CRC) remains a major global health concern, necessitating advancements in therapeutic strategies. Understanding the mechanisms driving CRC is crucial for developing effective treatments. Previous studies, including our own, highlight the role of six-transmembrane epithelial antigen of prostate 4 (STEAP4) in promoting colon tumorigenesis through reactive oxygen species (ROS) generation, making it a promising target. Our research provides compelling evidence that STEAP4 knockout significantly reduces colon tumorigenesis in a genetically engineered mouse model. Suppressing STEAP4 via knockdown techniques effectively attenuated the nuclear factor erythroid 2-related factor 2 (NRF2)–NAD(P)H:quinone oxidoreductase 1 (NQO1) signaling pathway, inducing apoptosis and autophagy, leading to substantial reductions in xenograft tumor growth. In contrast, STEAP4 overexpression amplified ROS production and activated the NRF2–NQO1 pathway in a ferric iron (Fe3+)-dependent manner. Notably, bioactivatable drugs targeting NQO1 were highly effective at eradicating STEAP4-overexpressing colon cancer cells. These findings highlight the potential of targeted therapeutic interventions for CRC, particularly through STEAP4 modulation. In conclusion, our study advances understanding of the role of STEAP4 in colon tumorigenesis, offering promising avenues for novel CRC treatments.Keywords
Funding Information
- National Institutes of Health (T32AI007538, R01ES035780, K01DK114390, P20 GM130422, 3P30CA118100-19S3)
- American Cancer Society (RSG-18-050-01-NEC)
- University of New Mexico (P50 MD015706, P30 CA118100, P42 ES025589, 1P30ES032755)
- University of New Mexico Health Sciences Center
This publication has 41 references indexed in Scilit:
- Iron promotes glycolysis to drive colon tumorigenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2023
- Enhanced Chemodynamic Therapy Mediated by a Tumor‐Specific Catalyst in Synergy with Mitophagy Inhibition Improves the Efficacy for Endometrial CancerSmall, 2023
- Ferroptosis in gastrointestinal cancer: from mechanisms to implicationsCancer Letters, 2023
- Transferrin Receptor‐Mediated Iron Uptake Promotes Colon TumorigenesisAdvanced Science, 2023
- Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancerCancer Letters, 2022
- The growth of siRNA-based therapeutics: Updated clinical studiesBiochemical Pharmacology, 2021
- Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disordersJournal of Allergy and Clinical Immunology, 2016
- Iron Uptake via DMT1 Integrates Cell Cycle with JAK-STAT3 Signaling to Promote Colorectal TumorigenesisCell Metabolism, 2016
- Association of the six transmembrane protein of prostate 2 gene polymorphisms with metabolic syndrome in Han Chinese populationDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2013
- Coordinated Regulation of Nutrient and Inflammatory Responses by STAMP2 Is Essential for Metabolic HomeostasisCell, 2007